COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 2

Associação hidroxicloroquina /cloroquina e azitromicina para COVID-19: revisão sistemática rápida

CONTEXTO: Publicações recentes têm chamado a atenção para o possível benefício da associação hidroxicloroquina/cloroquina e azitromicina no tratamento de pacientes infectados pelo novo coronavírus emergente (SARS-CoV-2). OBJETIVOS: Identificar, avaliar sistematicamente e sumarizar as melhores e...

Cloroquina, hidroxicloroquina, azitromicina como tratamiento para casos de COVID-19 moderado y severo

OBJETIVO: Vigiar la seguridad del uso de cloroquina fosfato, hidroxicloroquina y la combinación hidroxicloroquina + azitromicina en el tratamiento de casos moderados y severos de COVID-19, internados en centros hospitalarios de EsSalud, mediante farmacovigilância intensiva. METODOLOGÍA: Todos los paci...